Latanoprost in the management of angle closure glaucoma
- Author:
Tocyap Mary Lillian D
;
Lee Maria Regina A
;
Flores John Vincent d.G
;
Aquino Mario V
- Publication Type:Journal Article
- MeSH:
Human;
Male;
Female;
LATANOPROST;
INTRAOCULAR PRESSURE/DRUG EFFECTS;
GLAUCOMA, ANGLE-CLOSURE;
GLAUCOMA, ANGLE-CLOSURE/DRUG THERAPY;
HUMANS;
MALE;
FEMALE;
- From:
Philippine Journal of Ophthalmology
2002;27(1):21-26
- CountryPhilippines
- Language:English
-
Abstract:
Objective: To investigate the effect of latanoprost in IOP after laser iridectomy or filtering surgery Methodology: Patients of chronic angle closure glaucoma post laser iridectomy or filtering surgery were given latanoprost 0.005 percent eye drop in the evening for 2-6 weeks after a washout period ranging from 5 days - 28 days. IOP was measured at 9:00 a. m., 1:00 p.m. and 5: 00 p.m. per patient using a calibrated goldmann applanation tonometer Results: 29 patients were enrolled in study. There was a significant reduction in IOP among these patients Conclusion: Latanoprost 0.005 percent provides a significant reduction in IOP among patients with residual angle closure after laser iridectomy or filtering surgery. (Author)
